<DOC>
	<DOCNO>NCT00765024</DOCNO>
	<brief_summary>A prospective control trial compare efficacy safety 7-day albendazole , single dose ivermectin , 2-single dose ivermectin 72 patient chronic strongyloidiasis conduct Siriraj Hospital , Bangkok , Thailand .</brief_summary>
	<brief_title>Ivermectin Versus Albendazole Chronic Strongyloidiasis</brief_title>
	<detailed_description />
	<mesh_term>Strongyloidiasis</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Patients positive strongyloides larva stool Pregnancy Lactating woman Known allergy study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>strongyloidiasis , ivermectin , albendazole</keyword>
</DOC>